Nelson M - Search Results

1

A comparison of the CD4 response to antiretroviral regimens in patients commencing therapy with low CD4 counts.

Waters L, Stebbing J, Jones R, Michailidis C, Sawleshwarkar S, Mandalia S, Bower M, Nelson M, Gazzard B. Waters L, et al. Among authors: nelson m. J Antimicrob Chemother. 2004 Aug;54(2):503-7. doi: 10.1093/jac/dkh329. Epub 2004 Jun 16. J Antimicrob Chemother. 2004. PMID: 15201230 Clinical Trial.

2

Distribution of K103N and/or Y181C HIV-1 mutations by exposure to zidovudine and non-nucleoside reverse transcriptase inhibitors.

Torti C, Pozniak A, Nelson M, Hertogs K, Gazzard BG. Torti C, et al. Among authors: nelson m. J Antimicrob Chemother. 2001 Jul;48(1):113-6. doi: 10.1093/jac/48.1.113. J Antimicrob Chemother. 2001. PMID: 11418520

3

Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma.

Bower M, Nelson M, Young AM, Thirlwell C, Newsom-Davis T, Mandalia S, Dhillon T, Holmes P, Gazzard BG, Stebbing J. Bower M, et al. Among authors: nelson m. J Clin Oncol. 2005 Aug 1;23(22):5224-8. doi: 10.1200/JCO.2005.14.597. J Clin Oncol. 2005. PMID: 16051964

4

Assessment of the efficacy of total lymphocyte counts as predictors of AIDS defining infections in HIV-1 infected people.

Stebbing J, Sawleshwarkar S, Michailidis C, Jones R, Bower M, Mandalia S, Nelson M, Gazzard B. Stebbing J, et al. Among authors: nelson m. Postgrad Med J. 2005 Sep;81(959):586-8. doi: 10.1136/pgmj.2004.030841. Postgrad Med J. 2005. PMID: 16143689 Free PMC article.

5

Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone.

Jones R, Sawleshwarkar S, Michailidis C, Jackson A, Mandalia S, Stebbing J, Bower M, Nelson M, Gazzard BG, Moyle GJ. Jones R, et al. Among authors: nelson m. HIV Med. 2005 Nov;6(6):396-402. doi: 10.1111/j.1468-1293.2005.00325.x. HIV Med. 2005. PMID: 16268821 Free article.

6

A single centre cohort experience with a new once daily antiretroviral drug.

Stebbing J, Bower M, Holmes P, Gazzard B, Nelson M. Stebbing J, et al. Among authors: nelson m. Postgrad Med J. 2006 May;82(967):343-6. doi: 10.1136/pgmj.2006.044867. Postgrad Med J. 2006. PMID: 16679474 Free PMC article.

7

Highly active anti-retroviral therapy (HAART)-induced maintenance of adaptive but not innate immune parameters is associated with protection from HIV-induced mortality.

Stebbing J, Bower M, Mandalia S, Nelson M, Gazzard B. Stebbing J, et al. Among authors: nelson m. Clin Exp Immunol. 2006 Aug;145(2):271-6. doi: 10.1111/j.1365-2249.2006.03147.x. Clin Exp Immunol. 2006. PMID: 16879246 Free PMC article.

8

Pulmonary Kaposi sarcoma in the era of highly active antiretroviral therapy.

Palmieri C, Dhillon T, Thirlwell C, Newsom-Davis T, Young AM, Nelson M, Gazzard BG, Bower M. Palmieri C, et al. Among authors: nelson m. HIV Med. 2006 Jul;7(5):291-3. doi: 10.1111/j.1468-1293.2006.00378.x. HIV Med. 2006. PMID: 16945073 Free article.

9

The frequency and reasons for antiretroviral switching with specific antiretroviral associations: the SWITCH study.

Davidson I, Beardsell H, Smith B, Mandalia S, Bower M, Gazzard B, Nelson M, Stebbing J. Davidson I, et al. Among authors: nelson m. Antiviral Res. 2010 May;86(2):227-9. doi: 10.1016/j.antiviral.2010.03.001. Epub 2010 Mar 6. Antiviral Res. 2010. PMID: 20211651

10

Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma.

Bower M, Fox P, Fife K, Gill J, Nelson M, Gazzard B. Bower M, et al. Among authors: nelson m. AIDS. 1999 Oct 22;13(15):2105-11. doi: 10.1097/00002030-199910220-00014. AIDS. 1999. PMID: 10546864

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,525 results

Search Page

Filters